Jones Financial Companies
ORMP icon

Jones Financial Companies’s Oramed Pharmaceuticals ORMP Stock Holding History

Jones Financial Companies’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.09K Buy
933
+219
+31% +$743 ﹤0.01% 4018
2025
Q4 		$2.04K Hold
714
– – ﹤0.01% 3814
2025
Q3 		$1.72K Buy
714
+214
+43% +$473 ﹤0.01% 3742
2025
Q2 		$1.07K Hold
500
– – ﹤0.01% 3642
2025
Q1 		$1.1K Sell
500
-572
-53% -$1.32K ﹤0.01% 3378
2024
Q4 		$2.59K Buy
1,072
+500
+87% +$1.19K ﹤0.01% 2937
2024
Q3 		$1.42K Buy
+572
New +$1.4K ﹤0.01% 2748

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jones Financial Companies's ORMP Position: Q1 2026 in Review

Jones Financial Companies increased its Oramed Pharmaceuticals (ORMP) stake by 31% in Q1 2026, buying an estimated $743 and bringing the position to 933 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

Jones Financial Companies first reported a position in ORMP in Q3 2024 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Jones Financial Companies held 933 shares of Oramed Pharmaceuticals worth $3.09K as of Q1 2026.
  • Jones Financial Companies bought 219 Oramed Pharmaceuticals shares in Q1 2026, an estimated $743.
  • Oramed Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4018 holding.
  • Jones Financial Companies first reported a position in Oramed Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.